Yantai Zhenghai Biotechnology Co., Ltd. Stock price

Equities

300653

CNE100002NZ1

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
23.84 CNY +1.40% Intraday chart for Yantai Zhenghai Biotechnology Co., Ltd. -2.45% -17.85%
Sales 2023 * 431M 59.63M Sales 2024 * 523M 72.44M Capitalization 4.29B 594M
Net income 2023 * 188M 26.02M Net income 2024 * 229M 31.69M EV / Sales 2023 * 9.96 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 8.2 x
P/E ratio 2023 *
22.8 x
P/E ratio 2024 *
18.7 x
Employees 376
Yield 2023 *
2.1%
Yield 2024 *
2.52%
Free-Float 55.43%
More Fundamentals * Assessed data
Dynamic Chart
Zhenghai Bio-Tech Gets Nod for Oral Restorative Film MT
Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023. CI
Yantai Zhenghai Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares. CI
Yantai Zhenghai Biotechnology Co., Ltd. authorizes a Buyback Plan. CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Yantai Zhenghai Biotechnology Co., Ltd. Implements Final Cash Dividend of 10 A Shares for 2022, Payable on May 30, 2023 CI
Yantai Zhenghai Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2022 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Yantai Zhenghai Biotechnology Co., Ltd. Proposes Final Cash Dividend for the 2022 CI
Zhenghai Bio-Tech Enrolls First Subject for Uterine Cavity Repair Membrane Trial MT
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on May 19, 2022 CI
More news
1 day+1.40%
1 week-2.45%
Current month+0.59%
1 month+3.47%
3 months-16.93%
6 months-25.45%
Current year-17.85%
More quotes
1 week
23.17
Extreme 23.17
24.34
1 month
22.72
Extreme 22.72
25.20
Current year
18.11
Extreme 18.11
29.24
1 year
18.11
Extreme 18.11
49.78
3 years
18.11
Extreme 18.11
58.83
5 years
18.11
Extreme 18.11
58.83
10 years
6.88
Extreme 6.8756
58.83
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 16-11-17
Director of Finance/CFO 46 15-06-18
Corporate Secretary 42 15-06-18
Members of the board TitleAgeSince
Director/Board Member 58 15-06-18
Director/Board Member 41 15-06-18
Director of Finance/CFO 46 15-06-18
More insiders
Date Price Change Volume
24-03-28 23.84 +1.40% 1,922,109
24-03-27 23.51 0.00% 2,145,241
24-03-26 23.51 -1.96% 1,861,600
24-03-25 23.98 -1.11% 2,236,731
24-03-22 24.25 -0.78% 2,395,891

End-of-day quote Shenzhen S.E., March 27, 2024

More quotes
Yantai Zhenghai Bio-Tech Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of bio-regenerated materials. The Company's main products include the Heal-All branded oral cavity repair membranes, bio-membranes and bone repair materials, as well as the Heal-Full branded skin repair membranes, among others. The Company's products are mainly used in the fields of oral and neurosurgery. The Company mainly distributes its products in domestic markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.84 CNY
Average target price
35 CNY
Spread / Average Target
+46.83%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Yantai Zhenghai Biotechnology Co., Ltd. - Shenzhen S.E.